论文信息 - ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders. - 字舞流文

ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.

R. Abagyan | A. Cavalli | R. D. Di Martino | P. Storici | S. Girotto | José Antonio Ortega | Conall Sauvey | Debora Russo | B. Giabbai | B. Balboni | Da Shi | Stefania Demuro | Shailesh K. Tripathi